Conte aos seus amigos sobre este item:
Imatinib Mesylate in the Treatment of Chronic Myeloid Leukaemia: the Malaysian Experience Ping Chong Bee
Preço
R$ 250,90
excluindo impostos
Item sob encomenda (no estoque do fornecedor)
Espera-se estar pronto para envio 6 - 12 de out
Receba avisos sobre novos lançamentos de Ping Chong Bee
O que dizem nossos clientes:
Adicione à sua lista de desejos do iMusic
Imatinib Mesylate in the Treatment of Chronic Myeloid Leukaemia: the Malaysian Experience
Ping Chong Bee
Imatinib mesylate is a novel drug which targets the molecular level in chronic myeloid leukaemia. The response rates in various studies were very impressive. There is no study of efficacy and adverse effects of imatinib mesylate in our local patients. It is generally believed that these would be similar to that of Western patients. However, physical and genetic differences may influence the effects of imatinib mesylate in Asian patients.
| Mídia | Livros Paperback Book (Livro de capa flexível e brochura) |
| Lançado | 6 de julho de 2010 |
| ISBN13 | 9783838355832 |
| Editoras | LAP LAMBERT Academic Publishing |
| Páginas | 68 |
| Dimensões | 225 × 4 × 150 mm · 113 g |
| Idioma | Inglês |
